Combination effect of meropenem and antifungals against - dual-species biofilms and using a silkworm model.

Biofilms are a primary form of device-associated infections and typically exhibit high tolerance to antimicrobial agents. In biofilms formed by multiple microbial species, microorganisms may show even greater tolerance, complicating treatment. There is evidence that meropenem (MEPM) tolerance in is increased in dual-species biofilms with , and effective treatments have not been established. If the presence of viable increases the MEPM tolerance of in mature biofilms, then the killing of will attenuate the MEPM tolerance of . We evaluated the effectiveness of various antifungal combination treatments against dual-species biofilms of and and . The reduction in the number of viable cells in dual-species mature biofilms formed by and was evaluated after treatment with a combination of antifungal drugs (fluconazole, amphotericin B and micafungin) and MEPM. In addition, the effects of combination therapy were assessed using a silkworm biofilm infection model. The combination of amphotericin B and MEPM reduced the viable cell counts of both and within dual-species biofilms. In contrast, the combination of fluconazole and MEPM did not reduce the viable cell count of either species, whereas the combination of micafungin and MEPM reduced only. The reduction in viable counts by micafungin was less than that by amphotericin B, suggesting that micafungin did not affect the tolerance of . The combination of amphotericin B and MEPM also reduced the viable cell counts of both and in the model. These findings suggest that the combination of amphotericin B and antibacterial agents is a potential treatment option to reduce the -induced bacterial tolerance for catheter-related infections involving co-infection.